Skip to main content

Menopausal Hormone Therapy (MHT) discontinuation and shortages September 2024

Australia 

Patch Shortages

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia. Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

Oestradiol patches

 

Expected supply due

Alternative supply under Section 19A

Dose

Estradot

Estraderm

Estramon

Estradiol Transdermal System

25 mcg

20 Jan 2025

Available

Available

 

37.5 mcg

16 Dec 2024

 

Available

Available

50 mcg

20 Jan 2025

Available

Available

 Available

75 mcg

21 Oct 2024

11 Nov 2024

Available

Available

100 mcg

28 Oct 2024

Available

Available

Available

Combined patches

Dose

Estalis Sequi

Estalis Conti

50/140

Available

20 Sep 2024

50/250

Available

Available

All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.

The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

New Zealand

As at 17th September 2024, patch availability is provided below.

Dose

Estradot

Viatris

Estraderm MX

25mcg

Low

Available 

Available

50mcg

Low

Available

 

75mcg

Low

Available

 

100mcg

Low

Available

 

More information can be found here  

The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.